The trajectory of the erectile dysfunction drug presents a challenging picture for those considering investment. While the initial release generated significant profits, the lapse of its patent opened the floodgates to https://zakariavdex047812.mdkblog.com/47971474/sildenafil-and-pharma-a-volatile-opportunity